Skip to main content
logo
Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
64.13
-0.38 (-0.59%)
At close: Mar 23, 2026, 4:00 PM EDT
64.13
0.00 (0.00%)
After-hours: Mar 23, 2026, 4:02 PM EDT

Tarsus Pharmaceuticals Revenue

In the year 2025, Tarsus Pharmaceuticals had annual revenue of $451.36M with 146.71% growth. Tarsus Pharmaceuticals had revenue of $151.67M in the quarter ending December 31, 2025, with 128.39% growth.

Revenue (ttm)
$451.36M
Revenue Growth
+146.71%
P/S Ratio
6.18
Revenue / Employee
$1,219,892
Employees
370
Market Cap
2.73B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025451.36M268.41M146.71%
Dec 31, 2024182.95M165.51M948.62%
Dec 31, 202317.45M-8.37M-32.42%
Dec 31, 202225.82M-31.21M-54.73%
Dec 31, 202157.03M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Telix Pharmaceuticals803.79M
Catalyst Pharmaceuticals588.99M
Travere Therapeutics490.73M
Arcutis Biotherapeutics376.07M
Arcus Biosciences247.00M
IDEAYA Biosciences218.71M
Beam Therapeutics139.74M
Viridian Therapeutics70.85M
Revenue Rankings

TARS News

More News